Healthcare provider profile · identity verified

Christopher Michael Herman, MD

Internal Medicine · WINSTON SALEM, NC · NPI 1730156464

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	558	67
Eliquis	Apixaban	315	33
Amlodipine Besylate	Amlodipine Besylate	237	45
Donepezil Hcl	Donepezil Hcl	222	28
Memantine Hcl	Memantine Hcl	217	33
Losartan Potassium	Losartan Potassium	207	33
Furosemide	Furosemide	203	36
Mirtazapine	Mirtazapine	191	32
Atorvastatin Calcium	Atorvastatin Calcium	187	36
Tamsulosin Hcl	Tamsulosin Hcl	183	24
Lisinopril	Lisinopril	158	26
Gabapentin	Gabapentin	146	30
Metoprolol Succinate	Metoprolol Succinate	140	27
Pantoprazole Sodium	Pantoprazole Sodium	139	27
Trazodone Hcl	Trazodone Hcl	131	24
Escitalopram Oxalate	Escitalopram Oxalate	129	22
Potassium Chloride	Potassium Chloride	110	21
Metoprolol Tartrate	Metoprolol Tartrate	107	22
Paroxetine Hcl	Paroxetine Hcl	105	17
Divalproex Sodium	Divalproex Sodium	98	17
Prednisone	Prednisone	96	29
Duloxetine Hcl	Duloxetine Hcl	93	16
Omeprazole	Omeprazole	85	24
Myrbetriq	Mirabegron	84	15
Carvedilol	Carvedilol	83	13
Sertraline Hcl	Sertraline Hcl	83	18
Carbidopa-Levodopa	Carbidopa/Levodopa	82	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	82	18
Latanoprost	Latanoprost	80	14
Januvia	Sitagliptin Phosphate	77	suppressed
Levetiracetam	Levetiracetam	77	suppressed
Clopidogrel	Clopidogrel Bisulfate	76	12
Lorazepam	Lorazepam	74	41
Finasteride	Finasteride	70	12
Rosuvastatin Calcium	Rosuvastatin Calcium	69	11
Tramadol Hcl	Tramadol Hcl	69	27
Fluticasone Propionate	Fluticasone Propionate	65	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	14
Ketoconazole	Ketoconazole	64	16
Hydrochlorothiazide	Hydrochlorothiazide	61	suppressed
Famotidine	Famotidine	60	12
Celecoxib	Celecoxib	55	12
Xarelto	Rivaroxaban	54	suppressed
Torsemide	Torsemide	50	suppressed
Jardiance	Empagliflozin	48	suppressed
Timolol Maleate	Timolol Maleate	48	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	47	suppressed
Hydralazine Hcl	Hydralazine Hcl	46	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	45	suppressed
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	suppressed
Olanzapine	Olanzapine	43	suppressed
Ondansetron Hcl	Ondansetron Hcl	43	31
Ciprofloxacin Hcl	Ciprofloxacin Hcl	42	29
Aripiprazole	Aripiprazole	41	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	41	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	27
Metronidazole	Metronidazole	38	12
Atenolol	Atenolol	37	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	37	23
Ezetimibe	Ezetimibe	37	11
Amiodarone Hcl	Amiodarone Hcl	36	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	36	suppressed
Metformin Hcl	Metformin Hcl	35	suppressed
Buspirone Hcl	Buspirone Hcl	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	suppressed
Simvastatin	Simvastatin	33	suppressed
Brilinta	Ticagrelor	32	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	32	suppressed
Alendronate Sodium	Alendronate Sodium	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Valsartan	Valsartan	31	suppressed
Cephalexin	Cephalexin	30	16
Triamcinolone Acetonide	Triamcinolone Acetonide	30	17
Bupropion Xl	Bupropion Hcl	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Meloxicam	Meloxicam	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Travoprost	Travoprost	29	suppressed
Bumetanide	Bumetanide	28	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	28	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	27	12
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Levofloxacin	Levofloxacin	27	15
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Azithromycin	Azithromycin	26	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Memantine Hcl Er	Memantine Hcl	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	17
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Risperidone	Risperidone	24	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Amoxicillin	Amoxicillin	22	15
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	11
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Sotalol	Sotalol Hcl	21	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	20	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	20	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	20	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	20	11
Nystatin	Nystatin	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Ceftriaxone	Ceftriaxone Sodium	18	14
Chlorhexidine Gluconate	Chlorhexidine Gluconate	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Fluconazole	Fluconazole	18	14
Rivastigmine	Rivastigmine	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Estradiol	Estradiol	17	suppressed
Santyl	Collagenase Clostridium Hist.	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	16	suppressed
Lidocaine Hcl	Lidocaine Hcl	16	11
Morphine Sulfate	Morphine Sulfate	16	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Lactulose	Lactulose	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Budesonide	Budesonide	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Lithium Carbonate	Lithium Carbonate	14	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Methazolamide	Methazolamide	13	suppressed
Sodium Chloride	0.9 % Sodium Chloride	13	suppressed
Verapamil Sr	Verapamil Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Bethanechol Chloride	Bethanechol Chloride	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Guanfacine Hcl Er	Guanfacine Hcl	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Naproxen	Naproxen	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Ropinirole Er	Ropinirole Hcl	12	suppressed
Selegiline Hcl	Selegiline Hcl	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Digoxin	Digoxin	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Gemtesa	Vibegron	11	suppressed
Linzess	Linaclotide	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nyamyc	Nystatin	11	suppressed
Nystop	Nystatin	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error